AletheiaHQ
We're live on Product Hunt! Come say hi.
DIR-B8-36R-II7S/LVL 2·Guided ArbitrageGuided multi-step solo arbitrage producing a concrete deliverable. Requires basic commercial judgment. Examples: formatting extracted data into a $99 compliance checklist and cold-emailing 500 affected businesses; translating a buried scientific abstract into a viral short-form script monetised via affiliate links./88% confidence
Return to directory

Package NSF Commercialization Requirements into $297 Checklist

Organization
NSF SBIR Phase II solicitation documents (complex commercialization requirements)
Sector
SBIR Phase I awardees facing Phase II commercialization requirements
Location
Location unspecified
// Grantmaking Foundations// Curriculum Development// Grant Writing// Broadcasting & Publishing// Instructional Design// Behavioral Economics// Data Scraping// Design

Executive summary

Current state

ISEECHANGE, Inc. received $304,018 in SBIR Phase I funding to develop deep learning flood mapping technology but faces critical commercialization gaps as a small business with limited market access and implementation capacity. The NSF requires technical validation by December 2026, creating immediate pressure for Phase II application with commercialization components.

Market catalyst

SBIR Phase I companies receive $256K average funding but face immediate pressure to produce commercialization plans for Phase II - they need structured guidance but lack time to parse complex NSF documents

This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.

Field notes

Intelligence ledger

Shared context / revisions / signals

Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.

Sign in to add intelligence or vote on a field note.

Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.